Macrophage migration inhibitory factor produced by the tumour stroma but not by tumour cells regulates angiogenesis in the B16-F10 melanoma model

British Journal of Cancer

Volumn 107, Issue 9, 2012, Pages 1498-1505

  Girard, E ^a   Strathdee, C ^a   Trueblood, E ^a   Queva C ^a  

^a AMGEN INC   (United States)

Author keywords

angiogenesis; macrophage migration inhibitory factor; melanoma; MIF

Indexed keywords

ANTINEMATODAL AGENT; DOXYCYCLINE; ISO 1; MACROPHAGE MIGRATION INHIBITION FACTOR; NEUTRALIZING ANTIBODY; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; EX VIVO STUDY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STROMA CELL; TUMOR CELL; TUMOR GROWTH; VALIDATION PROCESS; VASCULARIZATION;

ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; HCT116 CELLS; HT29 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOVASCULARIZATION, PATHOLOGIC; RNA, SMALL INTERFERING; STROMAL CELLS; TRANSDUCTION, GENETIC;

EID: 84867902446     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.392     Document Type: Article

References (47)

1. Abe R, Peng T, Sailors J, Bucala R, Metz CN (2001) Regulation of the CTL response by macrophage migration inhibitory factor. J Immunol 166: 747-753
2. Apte RN, Dotan S, Elkabets M, White MR, Reich E, Carmi Y, Song X, Dvozkin T, Krelin Y, Voronov E (2006) The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev 25: 387-408
3. Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR, Dewor M, Georgiev I, Schober A, Leng L, Kooistra T, Fingerle-Rowson G, Ghezzi P, Kleemann R, McColl SR, Bucala R, Hickey MJ, Weber C (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13: 587-596
4. Bifulco C, McDaniel K, Leng L, Bucala R (2008) Tumor growth-promoting properties of macrophage migration inhibitory factor. Cur Pharm Des 14: 3790-3801
5. Bozza M, Satoskara R, Lin G, Lu B, Humbles A, Gerard C, David JR (1999) Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med 189: 341-346
6. Bucala R, Donnelly SC (2007) Macrophage migration inhibitory factor: a probable link between inflammation and cancer. Immunity 26: 281-285
7. Calandra T, Roger T (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3: 791-800
8. Chesney J, Metz C, Bacher M, Peng T, Meinhardt A, Bucala R (1999) An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol Med 5: 181-191
9. Culp WD, Tsagozis P, Burgio M, Russell P, Pisa P, Garland D (2007) Interference of macrophage migration inhibitory factor expression in a mouse melanoma inhibits tumor establishment by up-regulating thrombospondin-1. Mol Cancer Res 5: 1225-1231
10. Dessein A-F, Stechly L, Jonckheere N, Dumont P, Monté D, Leteurtre E, Truant S, Pruvot F-R, Figeac M, Hebbar M, Lecellier C-H, Lesuffleur T, Dessein R, Grard G, Dejonghe M-J, de Launoit Y, Furuichi Y, Prévost G, Porchet N, Gespach C, Huet G (2010) Autocrine induction of invasive and metastatic phenotypes by the MIF-CXCR4 axis in drug-resistant human colon cancer cells. Cancer Res 70: 4644-4654
11. Fingerle-Rowson G, Petrenko O (2007) MIF coordinates the cell cycle with DNA damage checkpoints. Lessons from knockout mouse models. Cell Div 222
12. Fingerle-Rowson G, Petrenko O, Metz CN, Forsthuber TG, Mitchell R, Huss R, Moll U, Müller W, Bucala R (2003) The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting Proc Natl Acad Sci USA 100: 9354-9359
13. Gregory JL, Morand EF, McKeown SJ, Ralph J a, Hall P, Yang YH, McColl SR, Hickey MJ (2006) Macrophage migration inhibitory factor induces macrophage recruitment via CC chemokine ligand 2. J Immunol 177: 8072-8079
14. Grieb G, Merk M, Bernhagen J (2010) Macrophage migration inhibitory factor (MIF): a promising biomarker. Drug News Perspect 23: 257-264
15. Honma N, Koseki H, Akasaka T, Nakayama T, Taniguchi M, Serizawa I, Akahori H, Osawa M, Mikayama T (2000) Deficiency of the macrophage migration inhibitory factor gene has no significant effect on endotoxaemia. Immunology 100: 84-90
16. Hudson JD, Shoaibi M a, Maestro R, Carnero A, Hannon GJ, Beach DH (1999) A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med 190: 1375-1382
17. Kleemann R, Hausser A, Geiger G, Mischke R, Burger-Kentischer A, Flieger O, Johannes FJ, Roger T, Calandra T, Kapurniotu A, Grell M, Finkelmeier D, Brunner H, Bernhagen J (2000) Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408: 211-216
18. Krockenberger M, Dombrowski Y, Weidler C, Ossadnik M, Hönig A, Häusler S, Voigt H, Becker JC, Leng L, Steinle A, Weller M, Bucala R, Dietl J, Wischhusen J (2008) Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D. J Immunol 180: 7338-7348
19. Kudrin A, Scott M, Martin S, Chung C-W, Donn R, McMaster A, Ellison S, Ray D, Ray K, Binks M (2006) Human macrophage migration inhibitory factor: a proven immunomodulatory cytokine? J Biol Chem 281: 29641-29651
20. Leng L, Chen L, Fan J, Greven D, Arjona A, Du X, Austin D, Kashgarian M, Yin Z, Huang XR, Lan HY, Lolis E, Nikolic-Paterson D, Bucala R (2011) A small-molecule macrophage migration inhibitory factor antagonist protects against glomerulonephritis in lupus-prone NZB/NZW F1 and MRL/lpr mice. J Immunol 186: 527-538
21. Leng L, Metz CN, Fang Y, Xu J, Donnelly S, Baugh J, Delohery T, Chen Y, Mitchell RA, Bucala R (2003) MIF signal transduction initiated by binding to CD74. J Exp Med 197: 1467-1476
22. Li G-Q, Xie J, Lei X-Y, Zhang L (2009) Macrophage migration inhibitory factor regulates proliferation of gastric cancer cells via the PI3K/Akt pathway. World J Gastroenterol 15: 5541
23. Lippa MS, Strockbine LD, Le TT, Branstetter DG, Strathdee CA, Holland PM (2007) Expression of anti-apoptotic factors modulates Apo2L/TRAIL resistance in colon carcinoma cells. Apoptosis 12: 1465-1478
24. Lue H, Dewor M, Leng L, Bucala R, Bernhagen J (2011) Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74. Cell Signal 23: 135-144
25. Lue H, Kapurniotu A, Fingerle-Rowson G, Roger T, Leng L, Thiele M, Calandra T, Bucala R, Bernhagen J (2006) Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity. Cell Signal 18: 688-703
26. Lue H, Thiele M, Franz J, Dahl E, Speckgens S, Leng L, Fingerle-Rowson G, Bucala R, Lüscher B, Bernhagen J (2007) Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene 26: 5046-5059
27. Merk M, Baugh J, Zierow S, Leng L, Pal U, Lee SJ, Ebert AD, Mizue Y, Trent JO, Mitchell R, Nickel W, Kavathas PB, Bernhagen J, Bucala R (2009) The Golgi-associated protein p115 mediates the secretion of macrophage migration inhibitory factor. J Immunol 182: 6896-6906
28. Meyer-Siegler KL, Iczkowski KA, Leng L, Bucala R, Vera PL (2006) Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells J Immunol 177: 8730-8739
29. Meyer-Siegler KL, Leifheit EC, Vera PL (2004) Inhibition of macrophage migration inhibitory factor decreases proliferation and cytokine expression in bladder cancer cells. BMC Cancer 4: 34
30. Mitchell RA, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J, Bucala R (2002) Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci USA 99: 345-350
31. Mittelbronn M, Platten M, Zeiner P, Dombrowski Y, Frank B, Zachskorn C, Harter PN, Weller M, Wischhusen J (2011) Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression. Acta neuropathol 122: 353-365
32. Nemajerova A, Mena P, Fingerle-Rowson G, Moll UM, Petrenko O (2007a) Impaired DNA damage checkpoint response in MIF-deficient mice. EMBO J 26: 987-997
33. Nemajerova A, Moll UM, Petrenko O, Fingerle-Rowson G (2007b) Macrophage migration inhibitory factor coordinates DNA damage response with the proteasomal control of the cell cycle. Cell Cycle 6: 1030-1034
34. Ogawa H, Nishihira J, Sato Y, Kondo M, Takahashi N, Oshima T, Todo S (2000) An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis. Cytokine 12: 309-314
35. Payne AS, Cornelius L (2002) The role of chemokines in melanoma tumor growth and metastasis. J Invest Dermatol 118: 915-922
36. Petrenko O, Moll UM (2005) Macrophage migration inhibitory factor MIF interferes with the Rb-E2F pathway. Mol Cell 17: 225-236
37. Ren Y, Chan HM, Fan J, Xie Y, Chen YX, Li W, Jiang GP, Liu Q, Meinhardt A, Tam PKH (2006) Inhibition of tumor growth and metastasis in vitro and in vivo by targeting macrophage migration inhibitory factor in human neuroblastoma. Oncogene 25: 3501-3508
38. Rendon BE, Willer SS, Zundel W, Mitchell RA (2009) Mechanisms of macrophage migration inhibitory factor (MIF)-dependent tumor microenvironmental adaptation. Exp Mol Pathol 86: 180-185
39. Schwartz V, Lue H, Kraemer S, Korbiel J, Krohn R, Ohl K, Bucala R, Weber C, Bernhagen J (2009) A functional heteromeric MIF receptor formed by CD74 and CXCR4. FEBS Lett 583: 2749-2757
40. Shi X, Leng L, Wang T, Wang W, Du X, Li J, McDonald C, Chen Z, Murphy JW, Lolis E, Noble P, Knudson W, Bucala R (2006) CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 25: 595-606
41. Verjans E, Noetzel E, Bektas N, Schütz AK, Lue H, Lennartz B, Hartmann A, Dahl E, Bernhagen J (2009) Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer. BMC Cancer 9: 230
42. Welford S, Bedogni B, Gradin K (2006) HIF1a delays premature senescence through the activation of MIF. Genes Dev 20: 3366-3371
43. White ES, Strom SR, Wys NL, Arenberg D (2001) Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activity. J Immunol 166: 7549-7555
44. Wilson JM, Coletta PL, Cuthbert RJ, Scott N, MacLennan K, Hawcroft G, Leng L, Lubetsky JB, Jin KK, Lolis E, Medina F, Brieva J, Poulsom R, Markham AF, Bucala R, Hull M (2005) Macrophage migration inhibitory factor promotes intestinal tumorigenesis. Gastroenterology 129: 1485-1503
45. Winner M, Koong AC, Rendon BE, Zundel W, Mitchell RA (2007) Amplification of Tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization. Cancer Res 67: 186
46. Wu Y, Li Y-Y, Matsushima K, Baba T, Mukaida N (2008) CCL3-CCR5 axis regulates intratumoral accumulation of leukocytes and fibroblasts and promotes angiogenesis in murine lung metastasis process. J Immunol 181: 6384-6393
47. Zhou Q, Yan X, Gershan J, Orentas RJ, Johnson BD (2008) Expression of macrophage migration inhibitory factor by neuroblastoma leads to the inhibition of antitumor T cell reactivity in vivo. J Immunol 181: 1877-1886